Refine your search
327 results found
Lexology PRO | Africa, Asia-Pacific, China, etc. | 15 Mar 2023
Copyright and trademarks: key updates for in-house teams (15 Jan – 15 March)
ChatGPT raises concerns relating to AI copyright and plagiarism, a UK court finds that Aldi infringed M&S’s gin bottle design, and China is set to further amend its trademark law – plus other key updates.
Zhong Lun Law Firm | China | 30 Jan 2023
关于企业合规第三方机制若干实务问题的Q&A（五）——药品安全合规监管与案件处置的十问十答（上）
近年来，受人口老龄化、疫情以及国家政策驱动等多方面影响，我国药品行业正处于快速发展的通道，根据国家药品监督管理…
Zhong Lun Law Firm | China | 28 Dec 2022
大健康行业年度法律观察
纵览2022年，新冠对社会经济生活影响深刻，大健康行业更深受影响。2018年国家医保局设立，2019年《药品管理法》全面…
Lexology PRO | China | 3 Aug 2022
China enacts “historic” futures and derivatives law
China has enacted its first “fundamental” futures and derivatives statute, making it a clean netting jurisdiction for the first time – but there are fears its new status could run its firms up against a rapidly-approaching global deadline.
Eagle IP Ltd | China | 2 Jun 2022
China Releases Draft Implementation Guidelines for the Drug Administration Law
The latest draft implementation guidelines for China’s Drug Administration Law (“Guidelines”) are out and open for comment. Previously, the new…
Hogan Lovells | USA | 21 Sep 2020
China’s NMPA releases proposal for modified “Hatch Waxman” following patent law reform
On 11 September 2020, China’s National Medical Products Administration (NMPA, formerly “China Food and Drug Administration”) published its proposed…
CCPIT Patent & Trademark Law Office | China | 24 Aug 2020
Introduction to the recent Draft Amendments to Patent Law
On June 20, 2020, the Standing Committee of the National People's Congress (NPC) published its 2020 version of draft amendments to Patent Law (2020…
Peksung Intellectual Property Ltd | China | 20 Apr 2020
中国仿制药的发展现状分析
仿制药是指与原研药在剂量、安全性、效力、质量、药效以及适应症上均相同的一种仿制药品。现代仿制药起源于1984…
Hogan Lovells | China | 27 Mar 2020
China takes a pragmatic approach to relaxing regulation of the life sciences sector during COVID-19
As the coronavirus (COVID-19) spreads across the world, creating new epicenters, this is perhaps an opportune moment to look back at the lessons…
Morgan, Lewis & Bockius LLP | USA | 12 Mar 2020
Recent FDA Medical Device Developments in Response to COVID-19
The US Food and Drug Administration is working to facilitate emergency use authorization for coronavirus (COVID-19) medical devices, including…
